Упрощенная HTML-версия
117
78.
Cockroft J.R. Preserved endothelium-dependent vasodilation in pa-
tients with essential hypertention / J.R. Cockroft, P.J. Chowienczyck, N. Ben-
jiamin et al. // N Engl J Med. – 1994. – V. 300. – P. 1036-1040.
79.
Cohen B. Modulation of insulin activities by leptin / B. Cohen, D.
Novick, M. Rubinstein // Science. – 1997. – V.274. – P. 1185-1188.
80.
Contreras F. Endothelial dysfunction in arterial hypertension / F.
Contreras, M. Rivera, J. Vasquez et al. // J Human Hypertens. – 2000. – V.14. –
Suppl 1. – S20-S25.
81.
Cooke J.P. Is NO an endogenous antiatherogenic molecule? / J.P.
Cooke, P.S. Tsao // Arterioscler. Thromb. – 1994. – V. 14. – P. 653-655.
82.
DeFronzo R.A. Insulin resistence: a multifaceted syndrome respon-
sible for NIDDM, obesity, hypertension, dyslipidemia and aterosclerothic cardio-
vascular disease / R.A. DeFronzo, E. Ferrannini // Diabetes Care. – 1991. – V.14.
– P.173-194.
83.
Despres J.P. Hyperinsulinemia as an independent risk factor for is-
chemic heart disease / J.P. Despres, B. Lamarche, P. Mauriege et al. // N Engl J
Med. – 1996. – V. 334. – P. 952-957.
84.
Dockrell M.E.C. Platelet aggregation in young men with contrasting
predisposition to high blood pressure / M.E.C. Dockrell // Am J Hypertens. –
1999. – V. 12. – P. 115-119.
85.
Dzau V.J. Endothelium and growth factors in vascular remodeling of
hypertension / V.J. Dzau, G.N. Gibbon // Hypertension. –1991. – V. 18. – Suppl.
III. – III 115 - III 121.
86.
Emilsson V. Expression of the functional leptin receptor mRNA in
pancreatic islets and direct inhibitory action of leptin on insulin secretion / V.
Emilsson, Y.-L. Liu, M.A. Cawthorne et al. // Diabetes. – 1999. – V. 46. – P.
313-336.